Ceramide enables fas to cap and kill

J Biol Chem. 2001 Jun 29;276(26):23954-61. doi: 10.1074/jbc.M101866200. Epub 2001 Apr 3.

Abstract

Recent studies suggest that trimerization of Fas is insufficient for apoptosis induction and indicate that super-aggregation of trimerized Fas might be prerequisite. For many cell surface receptors, cross-linking by multivalent ligands or antibodies induces their lateral segregation within the plasma membrane and co-localization into "caps" on one pole of the cell. In this study, we show that capping of Fas is essential for optimal function and that capping is ceramide-dependent. In Jurkat T lymphocytes and in primary cultures of hepatocytes, ceramide elevation was detected as early as 15-30 s and peaked at 1 min after CH-11 and Jo2 anti-Fas antibody treatment, respectively. Capping was detected 30 s after Fas ligation, peaked at 2 min, and was maintained at a lower level for as long as 30 min in both cell types. Ceramide generation appeared essential for capping. Acid sphingomyelinase -/- hepatocytes were defective in Jo2-induced ceramide generation, capping, and apoptosis, and nanomolar concentrations of C(16)-ceramide restored these events. To further explore the role of ceramide in capping of Fas, we employed FLAG-tagged soluble Fas ligand (sFasL), which binds trimerized Fas but is unable to induce capping or apoptosis in Jurkat cells. Cross-linking of sFasL with M2 anti-FLAG antibody induced both events. Pretreatment of cells with natural C(16)-ceramide bypassed the necessity for forced antibody cross-linking and enabled sFasL to cap and kill. The presence of intact sphingolipid-enriched membrane domains may be essential for Fas capping since their disruption with cholesterol-depleting agents abrogated capping and prevented apoptosis. These data suggest that capping is a ceramide-dependent event required for optimal Fas signaling in some cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies / immunology
  • Apoptosis* / drug effects
  • Cells, Cultured
  • Ceramides / biosynthesis
  • Ceramides / pharmacology
  • Ceramides / physiology*
  • Fas Ligand Protein
  • Hepatocytes / cytology
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Humans
  • Jurkat Cells
  • Kinetics
  • Membrane Glycoproteins / pharmacology
  • Membrane Microdomains / drug effects
  • Mice
  • Mice, Knockout
  • Receptor Aggregation
  • Sphingomyelin Phosphodiesterase / genetics
  • T-Lymphocytes / cytology
  • T-Lymphocytes / metabolism
  • fas Receptor / immunology
  • fas Receptor / metabolism*
  • fas Receptor / physiology*

Substances

  • Antibodies
  • Ceramides
  • FASLG protein, human
  • Fas Ligand Protein
  • Fasl protein, mouse
  • Membrane Glycoproteins
  • fas Receptor
  • acid sphingomyelinase-1
  • Sphingomyelin Phosphodiesterase